Rouen, France

Yvan René Ferdinand Simonnet

This inventor holds 3 USPTO granted patents and 1 EPO patent. Top assignee: Janssen Pharmaceutica Nv. Active years: 2009-2013.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yvan René Ferdinand Simonnet. Retrieved from https://idiyas.com/inventor/yvan-rene-ferdinand-simonnet

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


 

Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2009-2013

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Yvan René Ferdinand Simonnet: Pioneering Innovations in Pharmaceuticals

Introduction:

Yvan René Ferdinand Simonnet, hailing from Rouen, FR, is a visionary inventor whose passion for innovation has propelled him to the forefront of the inventors' realm. His relentless pursuit of excellence has solidified his position as a prominent figure in the world of inventors, inspiring future generations and shaping technological advancement.

Latest Patents:

Yvan René Ferdinand Simonnet's notable patent is on Substituted diaza-spiro-[4.5]-decane derivatives, showcasing their neurokinin antagonistic activity. These derivatives have shown efficacy in various medical applications such as schizophrenia, anxiety, depression, and chronic conditions like asthma and COPD. The patent encompasses their preparation, compositions, and utilization in the treatment and prophylaxis of a wide array of health conditions.

Career Highlights:

Currently affiliated with Janssen Pharmaceutica Nv, Yvan René Ferdinand Simonnet has been instrumental in driving groundbreaking research and development in the pharmaceutical industry. His expertise and innovative approach have led to the creation of impactful solutions that address unmet medical needs and improve patient outcomes.

Collaborations:

Collaborating closely with esteemed colleagues such as Frans E Janssens and Bruno Schoentjes, Yvan René Ferdinand Simonnet has fostered a culture of innovation and collaboration within the field of pharmaceuticals. Together, they have pioneered novel pharmaceutical compositions and treatments that have the potential to revolutionize healthcare practices worldwide.

Conclusion:

In conclusion, Yvan René Ferdinand Simonnet's unwavering commitment to innovation and his exceptional contributions to the field of pharmaceuticals underscore his legacy as a trailblazing inventor. His groundbreaking work continues to shape the landscape of medical science, offering hope and healing to countless individuals.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…